(Q42479900)

1 November 2017

β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation (English)

1 reference

1 November 2017

1 reference

1 reference

8

Jorge S Reis-Filho

1 reference

1 November 2017

7

Rachael Natrajan

1 reference

1 November 2017

5

Maryou B Lambros

1 reference

1 November 2017

1

Felipe C Geyer

1 reference

1 November 2017

2

Magali Lacroix-Triki

1 reference

1 November 2017

4

Monica Arnedos

1 reference

1 November 2017

Kay Savage

3

1 reference

PubMed ID

21076461

1 November 2017

Alan MacKay

series ordinal

6

1 reference

1 November 2017

12 November 2010

1 reference

1 November 2017

1 reference

1 November 2017

24

1 reference

1 November 2017

2

1 reference

1 November 2017

209-231

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.2010.205

1 November 2017

0 references

cites work

Beta-catenin and Tcfs in mammary development and cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Identification of c-MYC as a target of the APC pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Wnt signaling in hepatocellular carcinoma: analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Immunophenotypic and prognostic analysis of E-cadherin and beta-catenin expression during breast carcinogenesis and tumour progression: a comparative study with CD44.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

beta-Catenin and p53 analyses of a breast carcinoma tissue microarray.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Quantitative in situ analysis of beta-catenin expression in breast cancer shows decreased expression is associated with poor outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Cytoplasmic localization of beta-catenin is a marker of poor outcome in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Expression of S100A4, E-cadherin, alpha- and beta-catenin in breast cancer biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Fibromatosis of the breast and mutations involving the APC/beta-catenin pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Genetic changes of Wnt pathway genes are common events in metaplastic carcinomas of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Reduction of E-cadherin expression is associated with non-lobular breast carcinomas of basal-like and triple negative phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

PPM1D gene amplification and overexpression in breast cancer: a qRT-PCR and chromogenic in situ hybridization study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Target disruption of the mutant beta-catenin gene in colon cancer cell line HCT116: preservation of its malignant phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Nestin is expressed in basal-like and triple negative breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Most basal-like breast carcinomas demonstrate the same Rb-/p16+ immunophenotype as the HPV-related poorly differentiated squamous cell carcinomas which they resemble morphologically

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Patho-biological aspects of basal-like breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Metaplastic breast carcinomas are basal-like tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Refinement of breast cancer classification by molecular characterization of histological special types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Nuclear beta-catenin expression and Wnt signalling: in defence of the dogma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

APC and the three-hit hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Tiling path genomic profiling of grade 3 invasive ductal breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

7 January 2021

β-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

7 January 2021

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

7 January 2021

Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [seecomments]

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.205

7 January 2021

10.1038/MODPATHOL.2010.205

Identifiers

DOI

1 reference

PubMed ID

21076461

Dimensions Publication ID

1 November 2017

0 references

1 reference

PubMed ID

21076461